[1]杨绍玲,陈铭,李楠,等.胰腺纤维钙化性糖尿病1例并文献复习[J].国际内分泌代谢杂志,2017,37(05):355-357.
 Yang Shaoling,Chen Ming,Li Nan,et al.Fibrocalculous pancreatic diabetes:one case report and literature review[J].International Journal of Endocrinology and Metabolism,2017,37(05):355-357.
点击复制

胰腺纤维钙化性糖尿病1例并文献复习()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年05期
页码:
355-357
栏目:
病例报告
出版日期:
2017-09-20

文章信息/Info

Title:
Fibrocalculous pancreatic diabetes:one case report and literature review
作者:
杨绍玲陈铭李楠徐璐罗伊丽张曼娜卜乐林紫薇李鸿曲伸
200072 同济大学附属上海市第十人民医院内分泌科
Author(s):
Yang Shaoling Chen Ming Li Nan Xu Lu Luo Yili Zhang Manna Bu Le Lin Ziwei Li Hong Qu Shen.
Department of Endocrinology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
文献标志码:
A

参考文献/References:

[1] Zuidema PJ.Cirrhosis and disseminated calcification of the pancreas in patients with malnutrition[J]. Trop Geogr Med, 1959,11(1):70-74.
[2] Mohan V, Nagalotimath SJ, Yajnik CS, et al. Fibrocalculous pancreatic diabetes [J]. Diabetes Metab Rev, 1998,14(2):153-170.
[3] Hassan Z, MohanV, Ali L, et al. SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent[J]. Am J Hum Genet, 2002,71(4):964-968. DOI:10.1086/342731.
[4] Chowdhury ZM, MeDermott MF, Davey S, et al. Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family study [J]. Genes Immun, 2002,3(1):5-8. DOI:10.1038/sj.gene.6363814.
[5] Ewald N, Kaufmann C, Raspe A,et al. Prevalence of diabetes mellitus secondary to pancreatic diseases(type 3c)[J]. Diabetes Metab Res Rev,2012,28(4):338-342. DOI:10.1002/dmrr.2260.
[6] Govindarajan M, Mohan V, Deepa R, et al. Histopathology and immunohistochemistry of pancreatic islets in fibrocalculous pancreatic diabetes[J]. Diabetes Res Clin Pract,2001,51(1):29-38.
[7] Maisonneuve P, Lowenfels AB, Bueno-de-Mesquita HB, et al. Past medical history and pancreatic cancer risk: results from a multicenter case-control study[J]. Ann Epidemiol, 2010,20(2):92-98. DOI: 10.1016/j.annepidem.2009.11.010.
[8] Knop FK, Vilsbøll T, Larsen S, et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution[J]. Am J Physiol Endocrinol Metab,2007,292(1):E324-E330.DOI:10.1152/ajpendo.00059.2006.
[9] Kanta Barman K, Padmanabhan M, Premalatha G, et al. Prevalence of diabetic complication in fivrocalculous pancreatic diabetic patients and type 2 diabetic patients: a cross-sectional comparative study[J]. J Diabetes Complications, 2004, 18(5): 264-270. DOI: 10.1016 /S1056-8727(03)00074-6.
[10] Mohan V, Premalatha G, Padma A, et al. Fibrocalculous pancreatic diabetes. Long-term survival analysis[J]. Diabetes Care, 1996,19(11):1274-1278.
[11] Chari ST, Mohan V, Pitchumoni CS, et al. Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiological study[J]. Pancreas, 1994,9(1):62-66.
[12] Mittal N, Mehrotra R, Agarwal G,et al. The clinical spectrum of fibrocalculous pancreatic diabetes in north India[J]. Natl Med J India, 2002,15(6):327-331.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81500687); 国家重点研发计划资助项目(2016YFC1305601)
通信作者:李鸿,Email: lihong_endo@tongji.edu.cn
更新日期/Last Update: 2017-09-30